- Trials with a EudraCT protocol (680)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
680 result(s) found for: Terminal Disease.
Displaying page 1 of 34.
EudraCT Number: 2011-005678-47 | Sponsor Protocol Number: GED-301-02-11 | Start Date*: 2012-01-19 | |||||||||||
Sponsor Name:GIULIANI | |||||||||||||
Full Title: A phase II multi-center, randomized, double-blind, controlled vs placebo, long-term extension study to evaluate the safety and tolerability of 40 mg GED-0301for the maintainance of Crohn’s disease ... | |||||||||||||
Medical condition: CROHN'S DISEASE IN REMISSION PHASE | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022994-32 | Sponsor Protocol Number: 34009 | Start Date*: 2011-06-24 | ||||||||||||||||
Sponsor Name:UMC Utrecht | ||||||||||||||||||
Full Title: Effect of N-acetylcysteine on hydrogen sulfide in chronic kidney disease | ||||||||||||||||||
Medical condition: Chronic kidney disease End stage renal disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001924-40 | Sponsor Protocol Number: GED-0301-CD-003 | Start Date*: 2017-02-21 | |||||||||||
Sponsor Name:Celgene Corporation | |||||||||||||
Full Title: A Phase 3, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy and safety of mongersen (GED-0301) for the treatment of adult and adolescent subjects with act... | |||||||||||||
Medical condition: Active Crohn's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) GB (Prematurely Ended) CZ (Prematurely Ended) LV (Prematurely Ended) SK (Prematurely Ended) BE (Completed) DE (Prematurely Ended) DK (Prematurely Ended) NL (Prematurely Ended) HU (Prematurely Ended) GR (Prematurely Ended) FI (Prematurely Ended) PT (Prematurely Ended) ES (Prematurely Ended) FR (Prematurely Ended) PL (Prematurely Ended) HR (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001296-32 | Sponsor Protocol Number: FC/HULP-2014_01 | Start Date*: 2014-07-07 | ||||||||||||||||
Sponsor Name:Fundación para la Investigación Biomédica del Hospital Universitario de La Paz | ||||||||||||||||||
Full Title: Pharmacokinetic and pharmacodynamic optimization of amikacin treatment in patients with terminal renal failure under conventional hemodialysis: randomized clinical trial of two model of administration | ||||||||||||||||||
Medical condition: Terminal renal failure under hemodialysis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001963-37 | Sponsor Protocol Number: GED-0301-CD-004 | Start Date*: 2016-02-18 | |||||||||||
Sponsor Name:Celgene Corporation | |||||||||||||
Full Title: A Phase 3, long-term active treatment extension study of mongersen (GED-0301) in subjects with Crohn’s disease | |||||||||||||
Medical condition: Active Crohn's disease | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Prematurely Ended) EE (Prematurely Ended) SK (Completed) SE (Completed) HU (Completed) AT (Prematurely Ended) CZ (Prematurely Ended) GB (Prematurely Ended) DE (Prematurely Ended) ES (Prematurely Ended) PT (Prematurely Ended) BE (Completed) DK (Prematurely Ended) BG (Prematurely Ended) GR (Completed) HR (Prematurely Ended) FI (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000894-94 | Sponsor Protocol Number: KOR-PED-201 | Start Date*: 2021-08-26 | ||||||||||||||||
Sponsor Name:Vifor Fresenius Medical Care Renal Pharma Ltd. | ||||||||||||||||||
Full Title: An Open-label, Single Arm Study to Evaluate the Pharmacokinetics of a Single Dose of Intravenous Difelikefalin in Adolescents Aged 12 to 17 Years on Haemodialysis | ||||||||||||||||||
Medical condition: Renal disease in the final stage | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-002267-25 | Sponsor Protocol Number: PIVOTAL | Start Date*: 2013-09-06 | ||||||||||||||||||||||||||
Sponsor Name:King's College Hospital NHS Foundation Trust | ||||||||||||||||||||||||||||
Full Title: UK Multicentre Open-label Randomised Controlled Trial Of IV Iron Therapy In Incident Haemodialysis Patients | ||||||||||||||||||||||||||||
Medical condition: Iron-deficiency in anaemia of end stage renal disease. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-008246-20 | Sponsor Protocol Number: ABR 25995 | Start Date*: Information not available in EudraCT | |||||||||||||||||||||
Sponsor Name:Radboud University Nijmegen Medical Center, Department of Anaesthesiology, Pain and Palliative Medic | |||||||||||||||||||||||
Full Title: Evaluation of the efficacy and safety of sugammadex (Bridion) in children with renal failure. | |||||||||||||||||||||||
Medical condition: Sugammadex is a selective relaxant binding agent, which is administered in case of a rocuronium-induced neuromuscular block, during general anaesthesia. The aim of the trial is to investigate the u... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-016531-35 | Sponsor Protocol Number: SPD405-703 | Start Date*: 2010-05-18 | |||||||||||
Sponsor Name:Shire Pharmaceutical Development Ltd | |||||||||||||
Full Title: A Proof of Concept, Phase 2a, Double-blind, Parallel Group, Randomised, Placebo controlled Study to Assess the Effect of Lanthanum Carbonate on intact FGF23 in Normo-phosphataemic Subjects with Sta... | |||||||||||||
Medical condition: Chronic Kidney Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-018838-45 | Sponsor Protocol Number: RLY5016–204 | Start Date*: 2010-04-21 | ||||||||||||||||
Sponsor Name:Relypsa, Inc. | ||||||||||||||||||
Full Title: A Multicenter, Open-Label, Single-Arm Study to Evaluate a Titration Regimen for RLY5016 in Heart Failure Patients with Chronic Kidney Disease | ||||||||||||||||||
Medical condition: Heart failure with Chronic kidney disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SI (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-000856-16 | Sponsor Protocol Number: DTG_HD | Start Date*: 2015-05-27 | ||||||||||||||||
Sponsor Name:Fundació Lluita contra la SIDA | ||||||||||||||||||
Full Title: Removal of dolutegravir by hemodialysis in HIV-infected patients with end-stage renal disease. | ||||||||||||||||||
Medical condition: HIV-infected patients with end-stage renal disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-000948-98 | Sponsor Protocol Number: H-3-2011-154 | Start Date*: 2012-05-03 | |||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||
Full Title: Effect of epinephrine on systemic absorption of mepivacaine administered for brachial plexus block in patients with end-stage renal disease | |||||||||||||
Medical condition: End-stage renal disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000995-13 | Sponsor Protocol Number: DECODE-CKD | Start Date*: 2022-01-26 | |||||||||||
Sponsor Name:Department of Cardiology, Herlev and Gentofte hospital | |||||||||||||
Full Title: A 6-Month, Randomized, Double-Blind Study to Evaluate the Effect of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease (DECODE-CKD) | |||||||||||||
Medical condition: Chronic kidney disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000740-29 | Sponsor Protocol Number: 270389-030122 | Start Date*: 2022-04-12 | ||||||||||||||||
Sponsor Name:Department of Renal Medicine, Aarhus University Hospital | ||||||||||||||||||
Full Title: Sodium glucose cotransporter 2 inhibitors or Mineralocorticoid receptor antagonists for the treatment of Albuminuric Chronic Kidney Disease - A randomized controlled trial | ||||||||||||||||||
Medical condition: Chronic Kidney Disease with albuminuria | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-000431-40 | Sponsor Protocol Number: UF9672 | Start Date*: 2016-05-19 | |||||||||||
Sponsor Name:Health Ministry | |||||||||||||
Full Title: Randomized controlled study evaluating the effect of a biotherapy treatment (anti-RANKL ligand antibody: Denosumab) on bone and vascular metabolism in osteoporotic chronic kidney disease | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-003727-23 | Sponsor Protocol Number: RRK3563 | Start Date*: 2008-12-16 | |||||||||||
Sponsor Name:University Hospital Birmingham NHS Foundation Trust | |||||||||||||
Full Title: Does phosphate binding with sevelamer carbonate improve cardiovascular structure and function in patients with early chronic kidney disease? | |||||||||||||
Medical condition: Chronic kidney disease stage 3 (eGFR 30-59 ml/min/1.73m2) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002586-38 | Sponsor Protocol Number: RPH-1101 | Start Date*: 2011-10-14 | |||||||||||
Sponsor Name:Renapharma AB | |||||||||||||
Full Title: A 12-week clinical double-blind, randomised study of cholecalciferol versus placebo in patients with chronic kidney disease stage 3-4 (CHICK). | |||||||||||||
Medical condition: Chronic renal failure, stage 3-4 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000410-37 | Sponsor Protocol Number: 310107 | Start Date*: 2007-09-26 | |||||||||||
Sponsor Name:University Of Tuebingen | |||||||||||||
Full Title: Determination of glomerular filtration rate (GFR) using MR nephrography in patients with chronic kidney disease. | |||||||||||||
Medical condition: Chronic kidney disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016159-23 | Sponsor Protocol Number: ViRTUE-2009 | Start Date*: 2011-10-18 | |||||||||||
Sponsor Name:University Medical Center Groningen (UMCG) | |||||||||||||
Full Title: Vitamin D in addition to RAAS blockade and dietary sodium for the Treatment of Urinary Excretion of albumin: the ViRTUE-study | |||||||||||||
Medical condition: chronic kidney disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005003-88 | Sponsor Protocol Number: SIM15 | Start Date*: 2016-03-15 | |||||||||||
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and University of Cambridge | |||||||||||||
Full Title: Survival Improvement with Cholecalciferol in Patients on Dialysis – The SIMPLIFIED Registry Trial | |||||||||||||
Medical condition: Kidney Failure (requiring dialysis). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.